Skip to Content
    Greater Michigan Chapter
    Change Location

    Research Events

    Research Events

    As the largest nonprofit funder of Alzheimer's research, the Association is committed to accelerating the global progress of new treatments, preventions and, ultimately, a cure. The Association currently has more than $430 million invested in over 1,110 active projects in 56 countries spanning six continents. In Michigan, the Alzheimer's Association currently is funding 24 active projects totalling $4.6 million.
     

    The Alzheimer's Association Michigan Chapter offers research events that provide up-to-date information on what is currently known about Alzheimer's disease and other dementia and offer insight into where future research may be headed nationally and in Michigan. Researchers hail from Wayne State University in Detroit, the University of Michigan in Ann Arbor, Michigan State University in East Lansing, the surrounding Lansing area and Grand Rapids, and other esteemed institutions through the state.

    2026 Research Events

    The following research events are brought to you by the Alzheimer's Association in partnership with the Michigan Alzheimer's Disease Research Center:

    Tuesday, Feb. 24 | 12-1:15 p.m. | Zoom | Register
    Dr. Judy Heidebrink

    Wednesday, Feb. 25 | 6-7:30 p.m. | Spanish-language | Zoom | Registration link coming soon.\El enlace de registro estará disponible próximamente.

    Wednesday, May 6 | 10 a.m.-noon | Traverse City Masonic Lodge
    Dr. David Morgan

    Thursday, May 7 | 9:30-11:30 a.m. | Alpena Senior Citizens Center
    Dr. David Morgan 

    Stay tuned for research events also coming to Grand Rapids and Flint this year!

    Featured researchers


    Dr. Judy Heidebrink
     

    Heidebrink completed her Neurology residency, Geriatric Neurology fellowship, and M.S. in Clinical Research Design and Statistical Analysis at the University of Michigan. She directs the Neurology Cognitive Disorders Clinic and is co-leader of the Clinical Core of the MADRC. She has been involved in collaborative clinical trials in dementia for more than 20 years, including phase I-III studies focusing on the prevention and treatment of Alzheimer’s dementia. In addition, she has led the University of Michigan’s participation in the Alzheimer’s Disease Neuroimaging Initiative since the inception of this longitudinal observational study of brain imaging and other biomarkers in the progression from normal aging to dementia.


    Dr. Irving Vega

    Vega is the Red Cedar Distinguished Associate Professor in the Department of Translational Neuroscience at Michigan State University College of Human Medicine. He earned his B.S. in Biology from the University of Puerto Rico–Mayagüez and his Ph.D. in Molecular Biology and Neuroscience from Rutgers University, followed by postdoctoral training at Mayo Clinic Jacksonville. His research focuses on understanding the molecular and biochemical processes that lead to the accumulation of pathological proteins, particularly tau, which drive neurodegeneration in Alzheimer’s disease and related dementias. It also emphasizes community-engaged research to examine contextual and social factors that influence risk and resilience to neurodegenerative diseases across the lifespan.

    Dr. David Morgan

    Morgan is a Michigan State University Research Foundation professor and directopr of the College of Human Medicine Alzheimer's Alliance. He has more than 230 peer-reviewed publications and has been continuously funded from the National Institiutes of Helath since 1989, with over 100 grant-years of support. Morgan served for 6 years (2013-1019) on the program committee for the Alzheimer's Association International Conference, the last 3 years as chair.